Recruiting
PhII Randomized CAPecitabine + ELAcestrant vs. Capecitabine Alone in ER+ Breast Cancer (CAPELA)
NCT07222215
- Conditions
- Breast Cancer, Breast Diseases, Breast Neoplasms, +11 more
- Locations
-
- Dana-Farber Cancer Institute Boston, Massachusetts, United States